Blacksmith Medicines Announces Publication in Journal of Medicinal Chemistry Highlighting Discovery of a Non-Hydroxamate LpxC Inhibitor

Non-Hydroxamate LpxC InhibitorPositive

AI Analysis

Summary

Blacksmith Medicines announced the publication of research on a non-hydroxamate LpxC inhibitor in the Journal of Medicinal Chemistry, highlighting its discovery efforts targeting metalloenzymes.

Outcome Details

Publication in Journal of Medicinal Chemistry

Importance:2/10

Sentiment:

0.30

publicationresearchmetalloenzymeLpxC inhibitordrug discovery

Related Companies

$INTI $CBDY

Read the original article

Published by PR Newswire Pharma on August 5, 2026 2:00 PM

Read Original